Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-30 Sale | 2024-10-02 5:49 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $24.6 | $1,476,024 | 1,041,659 (Indirect Direct) | View |
| 2024-06-27 Sale | 2024-06-28 4:15 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $24.5 | $1,470,156 | 1,101,343 (Indirect Direct) | View |
| 2024-04-01 Sale | 2024-04-03 7:36 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 18,102 | $32.13 | $581,617 | 1,314,644 (Indirect Direct) | View |
| 2024-03-28 Sale | 2024-04-01 4:10 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $33.86 | $2,031,402 | 1,179,445 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 4:05 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $25.33 | $1,519,800 | 1,316,262 (Indirect Direct) | View |
| 2023-04-03 Sale | 2023-04-05 8:30 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 11,654 | $29.63 | $345,334 | 1,220,979 (Indirect Direct) | View |
| 2022-10-31 Sale | 2022-11-02 4:30 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $46.33 | $2,316,428 | 1,161,520 (Indirect Direct) | View |
| 2022-07-28 Sale | 2022-07-29 4:06 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $65.76 | $3,288,081 | 1,211,520 (Indirect Direct) | View |
| 2022-04-28 Sale | 2022-05-02 6:51 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $37.98 | $1,898,899 | 1,709,415 (Indirect Direct) | View |
| 2022-03-31 Sale | 2022-04-04 8:27 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 6,261 | $59.11 | $370,088 | 1,252,070 (Indirect Direct) | View |
| 2022-01-31 Sale(A) | 2022-02-02 6:00 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $66.84 | $3,341,903 | 2,963,840 (Indirect Direct) | View |
| 2021-10-06 Sale | 2021-10-08 4:21 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 47,700 | $83.8 | $3,997,268 | 1,548,170 (Indirect Direct) | View |
| 2021-08-19 Sale | 2021-08-20 6:05 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 20,000 | $99.49 | $1,989,744 | 1,595,870 (Indirect Direct) | View |
| 2021-07-07 Sale | 2021-07-08 6:00 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 25,000 | $107.87 | $2,696,826 | 1,615,870 (Indirect Direct) | View |
| 2021-04-21 Sale | 2021-04-23 4:45 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 25,000 | $70.49 | $1,762,216 | 1,640,774 (Indirect Direct) | View |
| 2020-12-30 Sale | 2021-01-04 5:31 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 22,300 | $84.94 | $1,894,125 | 1,193,957 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Option Award | 2024-04-03 7:36 pm | 2024-04-03 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 153,301 | $0 | 1,314,644 (Direct) | View |
| 2024-03-31 Option Award | 2024-04-01 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 77,500 | $0 | 1,179,445 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 155,000 | $24.4 | 1,316,262 (Direct) | View |
| 2023-03-06 Acquisition | 2023-03-31 7:48 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 225 | $0 | 1,541,557 (Direct) | View |
| 2023-03-31 Exercise | 2023-03-31 7:48 pm | N/A 2029-05-17 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 13,850 | $0 | 1,541,557 (Direct) | View |
| 2023-01-31 Option Award | 2023-03-31 7:48 pm | N/A 2033-01-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 168,750 | $0 | 1,541,557 (Direct) | View |
| 2023-03-31 Exercise | 2023-03-31 7:48 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 13,850 | $7.22 | 1,541,557 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:00 pm | N/A 2032-06-08 | Verve Therapeutics Inc. | VERV | Evans John M. Director | 15,500 | $0 | 15,500 (Direct) | View |
| 2022-04-28 Exercise | 2022-05-02 6:51 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 47,204 | $1.03 | 1,709,415 (Direct) | View |
| 2022-04-28 Exercise | 2022-05-02 6:51 pm | N/A 2029-05-17 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 59,450 | $0 | 1,709,415 (Direct) | View |
| 2022-04-28 Exercise | 2022-05-02 6:51 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 12,246 | $7.22 | 1,709,415 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 8:27 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 56,250 | $0 | 1,252,070 (Direct) | View |
| 2022-01-31 Exercise(A) | 2022-02-02 6:00 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 100,000 | $1.03 | 2,963,840 (Direct) | View |
| 2022-01-31 Exercise(A) | 2022-02-02 6:00 pm | N/A 2028-07-13 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 100,000 | $0 | 2,963,840 (Direct) | View |
| 2022-01-31 Option Award(A) | 2022-02-02 6:00 pm | N/A 2032-01-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 112,500 | $0 | 2,963,840 (Direct) | View |
| 2021-11-16 Gift(A) | 2022-02-02 6:00 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 12,000 | $0 | 2,963,840 (Direct) | View |
| 2021-10-06 Exercise | 2021-10-08 4:21 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 27,700 | $1.03 | 1,548,170 (Direct) | View |
| 2021-10-06 Exercise | 2021-10-08 4:21 pm | N/A 2028-07-13 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 27,700 | $0 | 1,548,170 (Direct) | View |
| 2020-02-05 Option Award(A) | 2021-09-21 6:00 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 153,300 | $0 | 153,300 (Direct) | View |
| 2021-08-19 Exercise | 2021-08-20 6:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 12,000 | $1.03 | 1,595,870 (Direct) | View |
| 2021-08-19 Exercise | 2021-08-20 6:05 pm | N/A 2028-07-13 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 12,000 | $0 | 1,595,870 (Direct) | View |
| 2021-07-07 Exercise | 2021-07-08 6:00 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 25,000 | $1.03 | 1,615,870 (Direct) | View |
| 2021-07-07 Exercise | 2021-07-08 6:00 pm | N/A 2028-07-13 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 25,000 | $0 | 1,615,870 (Direct) | View |
| 2021-06-25 Acquisition | 2021-06-30 6:00 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer | 64 | $0 | 1,244,557 (Direct) | View |
| 2021-06-29 Other | 2021-06-30 6:00 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer | 32 | $0 | 1,244,557 (Direct) | View |
Ownership | 2021-06-16 7:37 pm | N/A 2031-03-31 | Verve Therapeutics Inc. | VERV | Evans John M. Director | 0 | $0 | 43,198 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-23 4:45 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 6,000 | $1.03 | 1,640,774 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-23 4:45 pm | N/A 2028-07-13 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 6,000 | $0 | 1,640,774 (Direct) | View |
| 2021-03-18 Acquisition | 2021-04-12 7:29 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer | 97 | $0 | 1,263,429 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 5:20 pm | N/A 2031-03-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 208,125 | $0 | 1,402,082 (Direct) | View |
| 2020-04-16 Exercise | 2020-08-17 9:25 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 115,000 | $1.03 | 1,618,602 (Direct) | View |
| 2020-04-16 Exercise | 2020-08-17 9:25 pm | N/A 2028-07-13 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 115,000 | $0 | 1,618,602 (Direct) | View |
Ownership | 2020-02-05 7:34 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 0 | $0 | 1,841,602 (Direct) | View |